NVS' Cosentyx gains a positive CHMP recommendation for adolescents with moderate to severe HS, potentially expanding treatment options in Europe.
Novartis AG (NVS) — Live Session & Technical Brief
Updated Nov 16, 2026 1:05 PM ET · Prev Close $160.50
Session Regime & Catalyst Assessment
64% Signal ConvictionControlled Session Consolidation (+0.68%) in Drug Manufacturers - General
Novartis AG (Nvs) is trading within a tight intraday band at $161.59 (+0.68%, 0.41x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, NVS is outperforming the S&P 500 by +2.52%. 14-day RSI stands at 60.8, keeping momentum in a bullish regime.
NVS' Cosentyx gains a positive CHMP recommendation for adolescents with moderate to severe HS, potentially expanding treatment options in Europe.
Price ($161.59) holds above both 20-day ($159.19) and 50-day ($149.17) moving averages.
Market & Sector Relative Strength
NVS outperforming the S&P 500 by +2.52%Recent NVS Catalyst Headlines
Verified WireHere is how Novartis NVS and Alpha Cognition Inc. ACOG have performed compared to their sector so far this year.
Taipei, Tw Access Newswire November 16, 2026 OBI Pharma, Inc.Two Obi announced that it has entered into a Collaboration and License agreement with Novartis Pharma AG Novartis to develop next generation Antibody-Drug-Conj
If you only glanced at Siam Cement during a year of mixed earnings headlines and heated debates about environmental costs, the outcome may surprise you. Holding Siam Cement over the past year would have returned 33.3 , i
1–3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $159.19 (20-day SMA support) for directional breakout confirmation.
Technical Regime (NVS)
BULLISH MA TRENDRetail & Crowd Sentiment
NeutralAbout Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Get Instant NVS Catalyst Alerts
Receive an email alert when NVS triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversNVS Session & Catalyst FAQ
Why is NVS stock trading near flat today?
Novartis AG (Nvs) is trading within a tight intraday band at $161.59 (+0.68%, 0.41x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, NVS is outperforming the S&P 500 by +2.52%. 14-day RSI stands at 60.8, keeping momentum in a bullish regime.
Is NVS stock a buy or sell right now?
Today's session carries a 64% catalyst conviction score on 0.41x relative volume (low participation). Our multi-factor model currently rates NVS as HOLD. Review full valuation, quality, and timing signals on the NVS Buy or Sell Decision Brief →
What is NVS's intrinsic value and expected trading range?
At $161.59, NVS's modeled 1-to-3 session range is $157.20 – $165.98, with a key inflection level at $159.19 (20-day SMA support). Compare current price against multi-year cash flow projections in the NVS Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for NVS?
RSI at 60.8 reflects constructive bullish momentum. NVS trades at $161.59 relative to its 20-day SMA ($159.19) and 50-day SMA ($149.17), reflecting a bullish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.